Short Interest in Tema Oncology ETF (NASDAQ:CANC) Decreases By 67.6%

Tema Oncology ETF (NASDAQ:CANC) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totaling 8,604 shares, a drop of 67.6% from the April 15th total of 26,566 shares. Based on an average daily volume of 36,832 shares, the short-interest ratio is currently 0.2 days. Approximately 0.2% of the company’s stock are sold short.

Hedge Funds Weigh In On Tema Oncology ETF

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Thrivent Financial for Lutherans grew its stake in shares of Tema Oncology ETF by 891.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,461,649 shares of the company’s stock worth $50,747,000 after acquiring an additional 1,314,177 shares during the period. Jane Street Group LLC purchased a new stake in Tema Oncology ETF in the fourth quarter worth approximately $1,100,000. Flow Traders U.S. LLC bought a new stake in Tema Oncology ETF in the 3rd quarter worth approximately $630,000. LPL Financial LLC purchased a new stake in Tema Oncology ETF during the 4th quarter valued at $278,000. Finally, Roxbury Financial LLC purchased a new stake in Tema Oncology ETF during the 1st quarter valued at $34,000.

Tema Oncology ETF Stock Down 0.7%

Shares of NASDAQ CANC traded down $0.26 during midday trading on Thursday, hitting $37.86. The stock had a trading volume of 4,508 shares, compared to its average volume of 32,464. The business’s 50 day moving average is $37.21 and its 200-day moving average is $35.78. Tema Oncology ETF has a 52 week low of $22.48 and a 52 week high of $39.95. The company has a market cap of $177.56 million, a P/E ratio of 20.39 and a beta of 0.74.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.